news
Consortium established to monitor COVID-19 vaccines after marketing
A new consortium has been formed for the study of COVID-19 vaccines after their approval, to monitor their safety and efficacy.
List view / Grid view
University of Dundee
news
SFX‐01 to enter Phase II/III trials to test efficacy against COVID-19 symptoms
The drug candidate SFX-01 is set to be studied in Phase II/III trials to test its efficacy at treating acute respiratory distress syndrome (ARDS), a complication of COVID‐19.
news
£54 million funding to transform health through data science
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
news
Niclosamide could lead the fight against Parkinson’s disease
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson's disease...
news
Report highlights pharma’s key role in Scotland’s economy
Following new Fraser of Allander Institute analysis, the new Director of ABPI Scotland has called upon the Scottish Government to continue to support and prioritise strategic investments in Scotland’s research, development and manufacturing capabilities...
news
Ubiquigent and University of Dundee announce collaboration to develop novel ubiquitin system targeted compound libraries
8 October 2014 | By Ubiquigent and University of Dundee
Agreement brings together expertise to design, develop and market small molecule libraries targeting ubiquitin system proteins...
news
BioCity Scotland announced as UK hub for major European drug discovery project
7 February 2013 | By University of Dundee
"We are absolutely delighted that the European Lead Factory will be co-located in Scotland..."
news
Academia-pharma collaboration attracts £14.4million funding in the UK to accelerate drug discovery
14 May 2012 | By University of Dundee
The consortium includes six companies & will provide core support of £14.4 million...
article
Turn back the clock and be healed Induced pluripotent stem cells and their future impact on drug discovery and regenerative medicine
9 May 2010 | By Paul D. Andrews, Drug Discovery Unit, College of Life Sciences, University of Dundee
They are only four years old and are getting everyone very excited; they were Science Magazine’s ‘Breakthrough of the Year 2008’ and Nature’s ‘Method of the Year 2009.’ Their discoverer, Shinya Yamanaka, shared the Lasker Award last year and is no doubt touted for a future Nobel Prize. ‘They’ are…
article
Stem Cells Roundtable
Dr Paul Andrews (Senior Scientist, ITI Stem Cell Technology Programme, University of Dundee), Professor Peter Andrews (co-Director of the Centre for Stem Cell Biology, University of Sheffield), Fergus McKenzie PhD. (Programme Manager, ITI-Life Sciences), Dr Stephen Minger (Senior Lecturer in Stem Cell Biology, Kings College London) and Will Rust (Section…
